Pharmaceutical Technology Europe - August 2010 - (Page 1)
THE CHANGING LANDSCAPE FOR BIOSIMILARS 2 The biosimilars market may appear to present a lucrative opportunity but it is not without its obstacles and only the strongest will reap the rewards.
LATEST ISSUES AND INSIGHTS 3 6 7 8 9 10 Interview with The European Generic Medicines Association The biosimilars market today and tomorrow A SWOT analysis of the biosimilars market Latest EU guidelines dissected Taking on the regulators: is it worth it? Launching and commercialising biosimilars Perception, cost and the impact on biotech innovation Clinical and cost considerations of developing a biosimilar True biosimilars do not offer a compelling business case What is hindering the uptake of biosimilars?
Too steep a mountain to climb?
Getty Images/Javier Pierini
11 12 13 14
Table of Contents for the Digital Edition of Pharmaceutical Technology Europe - August 2010